Electromed Inc (ELMD)
Health Services • Health Care
April 28, 2026 Electromed, Inc. Prepares to Unveil Q3 Fiscal 2026 Financial Results Electromed, Inc. is set to release its Q3 fiscal 2026 financial results on May 12, 2026. A conference call will follow to discuss the results and future outlook, accessible via phone and webcast.
February 10, 2026 Electromed Inc. Reports Strong Q2 2026 Results Driven by Homecare Revenue Growth Electromed, Inc. reported a robust 16.2% increase in net revenues for Q2 2026, driven by strong homecare revenue growth. The company continues to focus on innovative airway clearance therapies, positioning itself well for future expansion.
November 12, 2025 Electromed Inc. Reports Strong Q1 2026 Financial Results Electromed Inc. reported a strong financial performance for Q1 2026, with a 15% increase in net revenue driven by a surge in hospital sales. The company continues to innovate in the airway clearance market, enhancing patient care.
August 26, 2025 Electromed Inc. Reports Robust Growth in 2025 Annual Results Electromed Inc. reported impressive financial growth for 2025, achieving $64 million in revenue, up from $54.71 million in 2024. The company emphasizes product innovation and faces challenges ahead but remains well-positioned in the pulmonary care market.
May 13, 2025 Electromed Inc. Reports Strong Q3 2025 Results: Growth in Homecare Revenue Amidst Challenges Electromed Inc. reported strong Q3 2025 results with a 13.6% revenue increase, driven by a surge in homecare sales. Despite challenges in the hospital segment, the company remains optimistic about future growth, focusing on product innovation and sales expansion.
May 13, 2025 Electromed, Inc. Reports Strong Q3 FY 2025 Financial Results Electromed, Inc. reported a 13.1% increase in net revenue for Q3 FY 2025, driven by strong demand for its SmartVest therapy. The company also announced a $5 million stock repurchase plan to enhance shareholder value.
April 29, 2025 Electromed Inc. Schedules Conference Call for Q3 Fiscal 2025 Financial Results Electromed Inc. will hold a conference call on May 13, 2025, to discuss its Q3 fiscal 2025 financial results. The company aims to provide clarity on its performance and strategic direction following the results release.
March 10, 2025 Electromed, Inc. Announces Share Repurchase Authorization: A Strategic Move for Shareholder Value Electromed, Inc. has announced a $5 million share repurchase program aimed at enhancing shareholder value by leveraging excess cash reserves. The company's board will review the program periodically, reflecting their commitment to responsive financial management and future growth opportunities.
February 26, 2025 Electromed Inc. Set to Showcase Innovations at Upcoming Investor Conferences Electromed, Inc. will showcase its airway clearance technologies at two significant investor conferences in March 2025. These events will enhance investor engagement and highlight the company's growth strategies and product innovations.
February 11, 2025 Electromed Inc. Reports Strong Q2 Results for 2025 Electromed Inc. showcased strong growth in Q2 2025 with a net income increase to $1.96 million and revenue reaching $16.25 million. The company's focus on innovation and effective cost management has solidified its position in the pulmonary care market.
February 11, 2025 Electromed Inc. Reports Record Financial Performance for Q2 FY 2025 Electromed, Inc. reported record financial results for Q2 FY 2025, with an 18.7% increase in net revenue to $16.3 million. Key growth drivers included a larger sales force and successful clinician engagement initiatives, reinforcing the company's position in the MedTech industry.
January 20, 2025 SWOT Analysis of Electromed Inc. in 2025 This SWOT analysis of Electromed Inc. in 2025 highlights its strengths in innovation and compliance, weaknesses in product reliance, and threats from competition. Opportunities for growth exist in expanding product lines and market presence.
November 12, 2024 Electromed Inc. Reports Strong Q1 2025 Results: Growth and Innovation Drive Performance Electromed Inc. reported strong Q1 2025 results with a 2.4% revenue increase driven by homecare and hospital sales growth. The company emphasizes innovation and effective management, positioning it for future success despite potential supply chain challenges.
August 27, 2024 Electromed Inc. Reports Strong Fiscal 2024 Results: Revenue and Net Income Surge Electromed Inc. reported a 12.6% revenue increase for FY 2024, driven by an expanded sales force and improved operational efficiencies. The company's net income surged to $5.15 million, highlighting strong profitability and a solid financial outlook for future growth.
May 07, 2024 Electromed Inc. Reports Strong Q3 2024 Financial Results Electromed Inc. reported strong Q3 2024 results with net revenues of $11.71 million, a 12% increase from last year. The company shows robust growth in both homecare and hospital segments, supported by cash flow improvements and solid liquidity.